Haemonetics Acquires Vivasure Medical

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.

Haemonetics to Acquire Attune Medical

March 5, 2024

Healthcare Services

Haemonetics Corporation has entered into a definitive agreement to acquire privately held Attune Medical, the manufacturer of the ensoETM proactive esophageal cooling device used during RF cardiac ablation procedures. The deal calls for an upfront cash payment of $160 million at closing, plus additional contingent consideration tied to sales growth and other milestones, and is expected to close in Haemonetics’ fiscal first quarter of 2025.

Haemonetics Corporation Acquires OpSens Inc.

December 12, 2023

Medical Devices

Haemonetics Corporation completed its acquisition of OpSens Inc. in an all-cash transaction for CAD $2.90 per share, representing a fully diluted equity value of approximately USD $255 million. The deal expands Haemonetics' hospital/interventional cardiology portfolio with OpSens' fiber-optic sensor technology (including the SavvyWire and OptoWire); OpSens will be delisted and Haemonetics expects OpSens to contribute $55–$65 million in revenue in fiscal 2025.

Surmodics Acquires Vetex Medical Limited

July 6, 2021

Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.

Second Sight Medical Products Merges With Nano Precision Medical to Form Vivani Medical

August 30, 2022

Healthcare Services

Second Sight Medical Products entered into a definitive all-stock agreement to acquire full ownership of privately held Nano Precision Medical, with NPM surviving the merger. The combined company (later renamed Vivani Medical) will focus on development of drug and device medical implants for chronic diseases, including NPM-119 for Type 2 diabetes and continued exploration of Second Sight’s Orion visual prosthesis.

MicroPort Scientific Acquires Hemovent GmbH

October 4, 2021

Medical Devices

MicroPort Scientific Corporation, through its critical care subsidiary MicroPort Surgical B.V., acquired 100% of Hemovent GmbH from its existing shareholders for up to €123 million in cash. Hemovent will become a wholly owned subsidiary of MicroPort, with completion expected in Q4 2021 following regulatory approvals.